Dosimetry and dose–response relationships in newly diagnosed patients with malignant gliomas treated with Iodine-131-Labeled anti-tenascin monoclonal antibody 81C6 therapy-Reference-Cited by-同舟云学术

Dosimetry and dose–response relationships in newly diagnosed patients with malignant gliomas treated with Iodine-131-Labeled anti-tenascin monoclonal antibody 81C6 therapy

Published:2000-03 Issue:4 Volume:46 Page:947-958
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Akabani Gamal,Cokgor Ilkcan,Coleman R.Edward,González Trotter Dinko,Wong Terence Z.,Friedman Henry S.,Friedman Allan H.,Garcia-Turner Ana,Herndon James E.,DeLong David,McLendon Roger E.,Zhao Xiao-Guang,Pegram Charles N.,Provenzale James M.,Bigner Darell D.,Zalutsky Michael R.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference34 articles.

1. An analysis of dose–response relationship in the radiotherapy of malignant gliomas;Walker;Int J Radiat Oncol Biol Phys,1979

2. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas; a co-operative clinical trial;Walker;J Neurosurg,1978

3. Radiotherapy for high grade gliomas;Sheline;Int J Radiat Oncol Biol Phys,1990

4. Malignant cerebral glioma—I;Davies;Br Med J,1996

5. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas;Chang;Cancer,1983

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical advances in TNC delivery vectors and their conjugate agents;Pharmacology & Therapeutics;2024-01

2. First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot study;EJNMMI Research;2023-09-04

3. Clinical application of radioiodinated antibodies: where are we?;Clinical and Translational Imaging;2022-01-11

4. Delivery of radioimmunotherapy for solid tumors;Systemic Drug Delivery Strategies;2022

5. Novel Human Tenascin-C Function-Blocking Camel Single Domain Nanobodies;Frontiers in Immunology;2021-03-15